University of Veterinary Medicine Vienna - Research portal

Diagrammed Link to Homepage University of Veterinary Medicine, Vienna

Müller Mathias,

Presentations at scientific conferences

Presentation

De Vries, LC; Wildenberg, ME; Willemze, RA; van Hamersveld, HP; Welting, O; Verseijden, C; Strobl, B; Mueller, M; D'Haens, GR; De Jonge, WJ (2018): Inhibition of tyrosine kinase 2 signalling ameliorates T cell transfer colitis. 13th Congress of ECCO, Vienna, Austria, FEB 14-17, 2018. J Crohns Colitis (12), S1 S73-S74.

Gracey, E; Muller, M; Miao, W; Westlin, W; Inman, RD (2018): TYK2 Promotes Il-23-Induced Type 3 Immunity And Disease Progression In Spondyloarthritis. 11th International Congress on Spondyloarthritides, Ghent, Belgium, OCT 4-6, 2018. Clin Exp Rheumatol (36), 4 735-735.

Porpaczy, E; Tripolt, S; Holbl-Kovacic, A; Gisslinger, B; Bago-Horvath, Z; Casanova-Hevia, E; Clappier, E; Decker, T; Fajmann, S; Fux, DA; Greiner, G; Gultekin, S; Heller, G; Herkner, H; Hormann, G [and 22 others] (2018): JAK1/2 inhibitor therapy-associated lymphomas in myelofibrosis arising from a preexisting B-cell clone. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Vienna, Austria, SEP 28 - OCT 2, 2018. Oncol Res Treat (41), S4 38-39.

Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Schlederer, M; Pham, HTT; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Muller, M; Rülicke, T; Moriggl, R (2016): Activated Stat5 Drives Peripheral T Cell Lymphomas. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016. Haematologica (101), S1 567-567.

Prutsch, N; Sanda, T; Turner, S; Wu, L; Müller, M; Jäger, U; Staber, P; Simonitsch-Klupp, I; Alvarez-Hernandez, A; Gurnhofer, E; Suske, T; Grebien, F; Stoiber, D; Schlederer, M; Moriggl, R [and 2 others] (2016): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A novel therapeutic intervention site? -Jahrestagung Österreichische Gesellschaft für Hämatologie und Onkologie (OeGHO); März 17-19, 2016; Vienna, Austria.

Prutsch, N; Sanda, T; Wu, L; Turner, S; Jaeger, U; Staber, P; Steinberger, P; Moriggl, R; Mueller, M; Kenner, L; Merkel, O (2016): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A new therapeutic intervention site. Jahrestagung der ­Deutschen, Österreichischen und ­Schweizerischen ­Gesellschaften für Hämatologie und ­Medizinische Onkologie, Leipzig, Germany, OCT 14–18, 2016. Oncol Res Treat (39), S3 239-239.

Grunert, T; Wenning, M; Sordelli, DO; Buzzola, FR; Wagener, K; Drillich, M; Monahan, A; Müller, M; Ehling-Schulz, M (2015): FTIR spectroscopy in host–pathogen interaction. -FT-IR Spectroscopy in Microbiological and Medical Diagnostics; OCT 15-16, 2015; Berlin, GERMANY.

Poelzl, A; Prchal-Murphy, M; Rom, R; Kaufmann, T; Lassnig, C; Mueller, M; Strobl, B (2015): Kinase-independent functions of Tyrosine kinase 2 (Tyk2) contribute to the pathogenesis of lipopolysaccharide (LPS)-induced endotoxemia. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, OCT 11-14, 2015. Cytokine (76), 1 90-90.

Prutsch, N; Sanda, T; Turner, S; Kubicek, S; Boidol, B; Jaeger, U; Simonitsch-Klupp, I; Schiefer, AI; Mueller, M; Wu, L; Kenner, L; Merkel, O (2015): The Tyk2 Pathway as a Novel Therapeutic Intervention Site in Aggressive T-Cell Lymphoma. 20th Congress of European-Hematology-Association, Vienna, AUSTRIA, JUN 11-14, 2015. Haematologica (100), S1 108-108.

Wienerroither, S; Shukla, P; Farlik, M; Majoros, A; Vogl, C; Cheon, H; Stark', G; Strobl, B; Müller, M; Decker, T (2015): Antimicrobial transcriptional response by integrated signals through STAT and NFkB pathways. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, OCT 11-14, 2015. Cytokine (76), 1 74-74.

Witalisz-Siepracka, A; Prchal-Murphy, M; Bednarik, K; Meissl, K; Putz, EM; Gotthardt, D; Sexl, V; Strobl, B; Müller, M (2015): Non-canonical TYK2 governs NK cell-mediated tumour surveillance. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, OCT 11-14, 2015. Cytokine (76), 1 79-79.

Parrini, M; Semper, C; Leitner, NR; Lassnig, C; Vogl, C; Wienerroither, S; Decker, T; Muller, M; Strobl, B (2014): STAT1 isoforms in transcriptional control - Distinct traits. 2nd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Melbourne, AUSTRALIA, OCT 26-29, 2014. Cytokine (70), 1 62-63.

Putz, EM; Leitner, NR; Müller, M; Sexl, V (2014): A novel non-canonical role of STAT1 in NK cells. -Natural Killer Cell Symposium; SEP 10-12, 2014; Hannover, GERMANY.

Stiedl, P; Blaas, L; Stanek, V; Svinka, J; Mahon, RM; Zollner, G; Claudel, T; Müller, M; Mikulits, W; Esterbauer, H; Eferl, R; Haybaeck, J; Trauner, M; Casanova, E (2014): The role of growth hormone receptor in liver fibrosis and cancer. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, APR 05-09, 2014. Cancer Res (74), 19

Biaggio, M; Lassnig, C; Reichart, U; Rom, R; Krmpotic, A; Jonjici, S; Strobl, B; Müller, M (2013): The role of STAT1 in macrophages/neutrophils in the response to murine cytomegalovirus infection. Annual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research, San Francisco, USA, SEP 29-OCT 03, 2013. Cytokine (63), 3 248-248.

Luckschander, N; Reichart, U; Richter, B; Allenspach, K; Haas, E; Bilek, A; Müller, M; Thalhammer, J (2013): The role of signal transducer and activation of transcription (stat) 3 in dogs with chronic enteropathies. -23th ECVIM-CA congress; SEP 12-14, 2013; Liverpool, UNITED KINGDOM.

Sanda, T; Tyner, JW; Gutierrez, A; Ngo, VN; Glover, JM; Chang, BH; Yost, AJ; Weng, AP; Ma, WX; Tatarek, J; Fleischman, AG; Ahn, Y; Yang, YD; Zhou, WJ; Neuberg, DS [and 8 others] (2012): TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, USA, DEC 08-11, 2012. Blood (120), 21

Wölbing, F; Marschall, J; Lassnig, C; Schulte, U; Kolb, A; Whitelaw, B; Müller, M; Biedermann, T; Huber, M (2012): CD13 is a negative regulator of Fc epsilon RI dependent mast cell activation in vitro and anaphylaxis in vivo. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg, GERMANY, MAR 01-03, 2012. Exp Dermatol (21), 3 e2-e2.

Kernbauer, E; Jamieson, AM; Schneckenleithner, C; Sexl, V; Reichart, U; Strobl, B; Müller, M; Decker, T (2011): Conditional ablation of Stat1 reveals the antagonistic role of interferons in the clearance of the intracellular bacterial pathogen Listeria monocytogenes. -9th Joint Meeting of the ICS/ISICR; Okt 9-12, 2011; Florence, Italy.

Kernbauer, E; Jamieson, AM; Schneckenleithner, C; Sexl, V; Reichart, U; Strobl, B; Müller, M; Decker, T (2011): Conditional ablation of Stat1 reveals the antagonistic role of interferons in the clearance of the intracellular bacterial pathogen Listeria monocytogenes. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, OCT 09-12, 2011. Cytokine (56), 1 10-11.

Majer, O; Bourgeois, C; Frohner, I; Müller, M; Decker, T; Kuchler, K (2010): Type I interferons modulate host immune response and outcome of Candida infections. 44th Annual Meeting of the German-Speaking Mycological Society (DMykG) together with the Austrian Society of Medical Mycology (ÖGMM), Vienna, Austria, SEP 9–11, 2010. Mycoses (53), 5 381-382.

Mueller, M (2010): Tissue-specific contribution of Stat1/3 to antiviral responses. -Doctoral Program Plus (DK-plus, W 1212-B09 ), Inflammation and Immunity, Interim Review Hearing (for 2nd period); Apr 15, 2010; Vienna, Austria.

Mueller, M (2010): Jaks and Stats in Disease - Focus on the Faces of Tyk2. -Comparative Medicine Seminar; JUN 24, 2010; Vienna, Austria.

Mueller, M (2010): The kinase side and the other side of Tyk2. -OeGMBT Jahrestagung 2010 ; Sept 27-29, 2010; Wien, Austria.

Mueller, M (2010): Jaks and Stats in Cancer – Focus on Stat3, Stat1 and Tyk2. -Bayer Schering Pharma AG; JUN 15, 2010; Berlin, Deutschland.

Mueller, M (2010): Genetics Of Laboratory Animals. -Toxicology Course Vienna; JUL 01-03, 2010; Vienna, Austria.

Uebel, C; Lehr, HA; Müller, M; Finotto, S (2010): The role of Tyrosine kinase 2 on Th17 development in a murine model of allergic asthma. Immunology 2010, NN, United States (USA), 2010. J Immunol (184), S1 141.7.

Anderl, S; Müller, S; Korthaus, D; Schmidt, V; Müller, M; Rülicke, T (2008): A New Kit Allel, Causing a Mild Phenotype in the Mouse. 272-273.-XX. International Congress of Genetics; JUL 12-17, 2008; Berlin, Deutschland.

Grunert, T; Strobl, B; Marchetti-Deschmann, M; Miller, I; Radwan, M; Vogl, C; Gemeiner, M; Allmaier, G; Müller, M (2008): The Effect of Tyk2 on Cellular Response in Activated Murine Macrophages Monitored by Quantitative Proteomics Analyses. 6th Austrian Proteome Research Symposium; SEP 15-16, 2008; Vienna, AUSTRIA. 2008.

Hofmann, E; Reichart, U; Gausterer, C; Meijer, D; Muller, M; Strobl, B (2008): OCT-6 (POU3F1, TST-1, SCIP) is an interferon-inducible protein. 7th Joint Conference of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytoklin-Research, Montreal, CANADA, OCT 12-16, 2008. Cytokine (43), 3 242-242.

Reutterer, B; Stockinger, S; Pilz, A; Soulat, D; Kastner, R; Westermayer, S; Rulicke, T; Müller, M; Decker, T (2008): Type I Interferons as virulence-determining factors in Listeria monocytogenes infections. Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, Austria, September 3–6, 2008. Wien Klin Wochenschr (120), Suppl. 56-56.

Decker, T; Kastner, R; Pilz, A; Reutterer, B; Soulat, D; Kalinke, U; Muller, M; Stockinger, S (2007): IFN-beta production increases the lethality of Listeria monocytogenes infection. 32nd FEBS Congress, Vienna, Austria, 7–12 July 2007. Febs J (274) 37-37.

Grebien, F; Kerenyi, MA; Kovacic, B; Kolbe, T; Klingmuller, U; Mueller, M; Beug, H; Moriggl, R; Mullner, EW (2007): Persistent Stat5 activation supports functional erythropoiesis in the absence of Jak2 and EPOR. ISEH 36th Annual Scientific Meeting, Hamburg, Germany, Sept. 28-30, 2007. Exp Hematol (35), 9 106-106.

Grebien, F; Kerenyi, MA; Kovacic, B; Kolbe, T; Klingmuller, U; Müller, M; Beug, H; Moriggl, R; Müllner, EW (2007): Persistent Stat5 activation supports functional erythropoiesis in the absence of Jak2 and EpoR. Keystone Meeting on Jaks, Stats and Immunity; 05. - 10. 01. 2007; Steamboat Springs, USA. 2007.

Karaghiosoff, M; Strobl, B; Costantino, G; Kolbe, T; Rülicke, T; Wagner, M; Sexl, V; Decker, T; Müller, M (2007): The Janus Face of Tyk2 in Pathogen Challenges. Keystone Meeting on Jaks, Stats and Immunity; 05. - 10. 01. 2007; Steamboat Springs, USA. 2007.

Reutterer, B; Stockinger, S; Pilz, A; Soulat, D; Rulicke, T; Muller, M; Decker, T (2007): Type I Interferons as virulence-determining factors in Listeria monocytogenes infections. 15th Annual Meeting of the International Cytokine Society, 15th Annual Meeting of the International Cytokine Society, San Francisco, California, 26-30 September 2007. Cytokine (39), 1 35-35.

Weichhart, T; Costantino, G; Poglitsch, M; Zeyda, M; Watschinger, B; Horl, WH; Muller, M; Saemann, MD (2007): The immunosuppressant rapamycin promotes toll-like receptor-mediated inflammatory responses. 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Prague, Czech Republic, 29 September -3 October 2007. Transplant Int (20) 54-54.

Sauer, I; Schaljo, B; Vogl, C; Gattermeier, I; Kolbe, T; Müller, M; Blackshear, PJ; Kovarik, P (2006): Interferons limit inflammatory responses by induction of tristetraprolin. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 70-70.

Staeheli, P; Dumoutier, L; Renauld, JC; Kalinke, U; Stech, J; Pavlovic, J; Müller, M; Kochs, G (2006): Inetrferon-[delta] contributes to influenza virus resistance. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 129-130.

Weichhart, T; Constantino, G; Zeyda, M; Poglitsch, M; Soleiman, A; Zlabinger, GJ; Hörl, WH; Müller, M; Säemann, MD (2006): Identification of the mammalian target of rapamycin (mTOR) as a regulator of innate immunity. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 101-101.

Miller, I; Radwan, M; Strobl, B; Vogl, C; Mueller, M; Gemeiner, M (2005): Spot patterns of lysed mouse macrophages; What comes from cell culture medium. HUPO 4th Annual World Congress, Munich, August 28–September 1, 2005. Mol Cell Proteomics (4), 8S1 S230-S230.

Stoiber, D; Kovacic, B; Schuster, C; Schellack, C; Karaghiosoff, M; Kleine, OC; Kreibich, R; Weisz, E; Mueller, M; Sexl, V (2004): Impact of TYK2 on Abelson-induced tumour formation. 10th Symposium of the Austrian-Pharmacological-Society, Vienna, AUSTRIA, SEP 23-26, 2004. Pharmacology (72), 2 130-130.

Kerschbaumer, P; Steinborn, R; Walzer, Ch; Müller, M; Schwarzenberger, F (2003): Mitochondrial DNA mutations as possible cause for disease predisposition and progressive neurodegenerative disease in the cheetah (Acinonyx jubatus). Verhandlungsbericht des 41. Internationalen Symposiums über die Erkrankungen der Zoo- und Wildtiere, Rome, Italy, MAY 28 - JUN 01, 2003. Erkrankungen der Zootiere. Verhandlungsbericht des Internationalen Symposiums über die Erkrankungen der Zoo- und Wildtiere 7-9.

Klymiuk, N; Mueller, M; Brem, G; Aigner, B (2003): High frequency of recombined sequences in human tropic porcine endogenous retroviruses. 7th Congress of the International-Xenotransplantation-Association, GLASGOW, SCOTLAND, Xenotransplantation (10), 5 491-491.

Müller, M (2001): Increasing disease resistance in transgenic domestic animals. 87-97.-OECD Workshop on Molecular Farming; SEP 03-06, 2000; Grande Motte, France. IN: Toutant, JP [Hrsg.]: Molecular farming: Proceedings of the OECD Workshop held in La Grande Motte;

Poster

Maurer, B; Pham, HTT; Prchal-Murphy, M; Nivarthi, H; Wingelhofer, B; Schlederer, M; Grausenburger, R; Winkler, S; Halbritter, F; Farlik, M; Bock, C; Kenner, L; Kolbe, T; Rülicke, T; Müller, M [and 2 others] (2017): Graded STAT5A or STAT5B activity promote T-cell neoplasia. STATs: Importance In Basic & Clinical Cancer Research; Nov 15-18, 2017; Cold Spring Harbor, United States (USA). 2017.

Tripolt, S; Porpaczy, EA; Hoelbl-Kovacic, A; Gisslinger, B; Bago-Horvath, Z; Casanova, E; Decker, T; Fux, D; Heller, G; Herkner, H; Kolbe, T; Kornauth, C; Mueller, M; Prchal-Murphy, M; Schiefer, AI [and 14 others] (2017): JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model. 59th Annual Meeting of the American Society of Hematology; DEC 09-12,2017; Atlanta, United States (USA). 2017.

Tripolt, S; Porpaczy, EA; Hoelbl-Kovacic, A; Gisslinger, B; Bago-Horvath, Z; Casanova, E; Decker, T; Fux, DA; Heller, G; Herkner, H; Kolbe, T; Kornauth, C; Mueller, M; Prchal-Murphy, M; Schiefer, IA [and 14 others] (2017): JAK1/2-inhibitor therapy associated lymphomas in myelofibrosis: Distinct clinico-pathological features recapitulated in a mouse model. 59th ASH Annual Meeting and Exposition; DEZ 9-12,2017; Atlanta, Georgia, United States (USA). 2017.

Bozovic, N; Lassnig, C; Stockinger, S; Meissl, K; Strobl, B; Müller, M (2016): Non-Canonical and Cell Type-Specific Functions of TYK2 in the Defence Against Listeria Monocytogenes. 4th Annual Meeting of The International-Cytokine-and-Interferon-Society (ICIS), San Francisco, CA, OCT 16-19, 2016. Cytokine (87) 131-132.

Bozovic, N; Lassnig, C; Stockinger, S; Meissl, K; Strobl, B; Müller, M (2016): Non-canonical and cell type-specific functions of TYK2 in the defence against Listeria monocytogenes. -4th Annual Meeting of the International Cytokine and Interferon Society (ICIS); OCT 16-19, 2016; San Francisco, CA, USA.

Crncec, I; Gordziel, C; Pathria, P; Modak, M; Stöckl, J; Wallner, B; Strobl, B; Leitner, N; Müller, M; Rauch, I; Decker, T; Schlederer, M; Kenner, L; Friedrich, K; Eferl, R (2016): The role of STAT1 in colitis-associated colorectal cancer. -Bridge Gaps Cross Roads - Joint Symposium of 4 PhD programs - CCHD, IAI, ICA, MCCA; FEB 1-3, 2016; Vienna, AUSTRIA.

Gawish, R; Biaggio, M; Lassnig, C; Bago-Horvath, Z; Rom, R; Amenitsch, L; Kornoff, J; Bokor, M; Krmpotic, A; Sonjic, S; Strobl, B; Müller, M (2016): Myeloid interferon signaling protects from murine CMV infection and promotes extramedullary hematopoiesis. -EMDS 2016; SEP 21-23, 2016; Amsterdam, NETHERLAND.

Meissl, K; Parrini, M; Puga, A; Semper, C; Lassnig, C; Müller, M; Strobl, B (2016): Alternatively spliced isoforms of STAT1 in cytokine signaling and immunity. -1st International Caparica Conference on Splicing; SEP 12-14, 2016; Lisabon, PORTUGAL.

Meissl, K; Witalisz-Siepracka, A; Prchal-Murphy, M; Sexl, V; Müller, M; Strobl, B (2016): Cell-extrinsic STAT1 isoform-specific functions regulate NK cell maturation. -16th Annual Meeting of the Society for Natural Immunity - NK2016; OCT 3-5, 2016; Taormina, ITALY.

Pflügler, S; Svinka, J; Pathria, P; Knapp, N; Strobl, B; Müller, M; Eferl, R (2016): The role of Stat3 in polarization of tumor-associated macrophages. - Bridge Gaps Cross Roads. -Joint Symposium of 4 PhD programs - CCHD, IAI, ICA, MCCA; FEB 1-3, 2016; Vienna, AUSTRIA.

Poelzl, A; Prchal-Murphy, M; Gawish, R; Rom, R; Lassnig, C; Mueller, M; Strobl, B (2016): Kinase Dependent- and Independent Functions of Tyrosine Kinase 2 (TYK2) During Endotoxemia. 8th Congress of the International-Federation-of-Shock-Societies, Tokyo, JAPAN, OCT 03-05, 2016. Shock (46), 4 S2 64-64.

Pölzl, A; Prchal-Murphy, M; Gawish, R; Rom, R; Lassnig, C; Müller, M; Strobl, B (2016): Kinase dependent and independent functions of tyrosine kinase 2 (TYK2) during endotoxemia. -The 8th Congress of the International Federation of Shock Societies - International Shock Congress 2016 Tokyo; OCT 3-5, 2016; Tokyo, JAPAN.

Puga, A; Parrini, M; Meissl, K; Lassnig, C; Decker, T; Müller, M; Strobl, B (2016): STAT1 isoform specific functions in infectious and inflammatory diseases. -Joint Symposium of 4 PhD programs - CCHD, IAI, ICA, MCCA; FEB 1-3, 2016; Vienna, AUSTRIA.

Puga, A; Parrini, M; Meissl, K; Lassnig, C; Decker, T; Müller, M; Strobl, B (2016): The role of STAT1 isoforms in inflammation and intestinal antibacterial immunity. -Cytokines 2016 - 4th Annual Meeting of the International Cytokine and Interferon Society; OCT 16-19, 2016; San Francisco, CA, USA.

Puga, A; Parrini, M; Meissl, K; Lassnig, C; Decker, T; Müller, M; Strobl, B (2016): STAT1 isoform specific function in innate and adaptive immunity. -YSA PhD Symposium 2016; FEB 1, 2016; Vienna, AUSTRIA.

Puga, A; Parrini, M; Meissl, K; Lassnig, C; Decker, T; Müller, M; Strobl, B (2016): The Role of STAT1 Isoforms in Inflammation and Intestinal Antibacterial Immunity. 4th Annual Meeting of The International-Cytokine-and-Interferon-Society (ICIS), San Francisco, CA, OCT 16-19, 2016. Cytokine (87) 74-74.

Sexl, V; Gotthart, D; Putz, EM; Witalisz, A; Decker, T; Strobl, B; Müller, M (2016): AK-STAT in NK cells: For the better or worse in tumour surveillance. -Cytokine JAK-STAT Signaling in Immunity and Disease; JAN 10-14, 2016; Colorado, USA.

Witalisz-Siepracka, A; Bozovic, N; Meissl, K; Lassnig, C; Sexl, V; Müller, M; Strobl, B (2016): TYK2 regulates NK cell function by cell-intrinsic and -extrinsic mechanisms. -NK 2016 - 16th Meeting of the Society for Natural Immunity; OCT 3-5, 2016; Taormina, ITALY.

Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Prochazkova, J; Schlederer, M; Pham, H; Loizou, JI; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Müller, M [and 2 others] (2015): An activating STAT5 mutation is sufficient for Peripheral T Cell Lymphoma formation. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, OCT 11-14, 2015. Cytokine (76), 1 77-77.

Stiedl, P; McMahon, R; Blaas, L; Stanek, V; Svinka, J; Grabner, B; Zollner, G; Kressler, S; Claudel, T; Müller, M; Mikulits, W; Esterbauer, H; Eferl, R; Haybaeck, J; Trauner, M; Casanova, E (2015): The Role of Growth Hormone Receptor in Liver Fibrosis and Cancer. 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, APR 22-26, 2015. J Hepatol (62), S2 S792-S792.

Biaggio, M; Lassnig, C; Rom, R; Krmpotic, A; Jonjic, S; Strobl, B; Müller, M (2014): STAT1 in myeloid cells is required to limit early replication of murine cytomegalovirus and its persistence in salivary glands. -10th YSA-Workshop of the Young Scientist Association (YSA); Juni 11-12, 2014; Medical University of Vienna (MUW Vienna).

Biaggio, M; Lassnig, C; Rom, R; Krmpotic, A; Jonjic, S; Strobl, B; Müller, M (2014): STAT1 in myeloid cells is required to limit early replication and persistence of murine cytomegalovirus in vivo. -28th International Conference of the EMDS ; OKT 2-4, 2014; Vienna, Austria.

Gotthardt, D; Putz, EM; Straka, E; Kudweis, P; Strobl,B; Mathias, M; Sexl, V (2014): Loss of STAT3 in Natural Killer Cells enhances NK cell dependent tumor surveillance. -10th YSA-PhD-Symposium 2014; JUN, 2014; Vienna, AUSTRIA.

Leopold Wagner, CM; Hole, CR; Wozniak, KL; Olszewski, MA; Müller, M; Wormley, FLJ (2014): STAT1-Induced Classical Macrophage Activation is Essential for Protection against Cryptococcus neoformans in Mice. -9th International Conference on Cryptococcus and Cryptococcosis; MAI 15-19, 2014; Amsterdam, Niederlande.

Maier, B; Strobl, B; Müller, M; Knapp, S (2014): Role of type I interferon during pneumococcal pneumonia in vivo. -28th International Conference of the EMDS; OKT 2-4, 2014; Vienna, Austria.

Majoros, A; Cheon, H; Shukla, P; Vogl, C; Schreiber, RD; Stark, G; Müller, M; Decker, T (2014): Evidence for phospho-tyrosine independent signaling activity of Stat1. -28th International Conference of the EMDS ; OKT 2-4, 2014; Vienna, Austria.

Meissl, K; Klein, K; Witalisz, A; Prchal-Murphy, M; Sexl, V; Müller, M; Strobl, B (2014): STAT1 isoform specific functions in NK cell maturation and cytotoxicity. -Natural Killer Cell Symposium ; Sept 10-14, 2014; Hannover, Germany.

Parrini, M; Semper, C; Leitner, NR; Lassnig, C; Vogl, C; Wienerroither, S; Decker, T; Müller, M; Strobl, B (2014): It takes two - STAT1 isoforms and their distinct features in macrophages. -28th International Conference of the EMDS ; OKT 2-4, 2014; Vienna, Austria.

Putz, EM; Leitner, NR; Müller, M; Sexl, V (2014): A novel non-canonical role of STAT1 in NK cells. -6th ÖGMBT Annual Meeting ; Sept 15-18, 2014; Vienna, Austria.

Sexl, V; Putz, EM; Gotthardt, D; Strobl, B; Decker, T; Müller, M (2014): STATs in the spotlight of NK cell mediated immune surveillance. -6th ÖGMBT Annual Meeting ; Sept 15-18, 2014; Vienna, Austria.

Wienerroither, S; Shukla, P; Farlik, M; Majoros, A; Vogl, C; Müller, M; Decker, T (2014): Concerted recruitment of the mediator complex explains STAT-NFkB interaction in the antimicrobial response of macrophages. -28th International Conference of the EMDS; OKT 2-4, 2014; Vienna, AUSTRIA.

Witalisz, A; Prchal-Murphy, M; Bednarik, K; Meissl, K; Sexl, V; Strobl, B; Müller, M (2014): Kinase-inactive Tyk2 mediates NK cell-dependent tumour surveillance and CD8+ T cell crosstalk to NK cells. -Natural Killer Cell Symposium; Sept 10-14, 2014; Hannover, Germany.

Bourgeois, C; Zwolanek, F; Majer, O; Glaser, W; Mueller, M; Kuchler, K (2012): Type I-interferon signaling promotes Candida glabrata persistence by modulating immune effector cell recruitment and/or differentiation. 18th Congress of the International Society for Human and Animal Mycology, Berlin, Germany, JUN 11-15, 2012. Mycoses (55), S4 318-318.

Bauer, E; Vielnascher, R; Prchal, M; Strobl, B; Müller, M; Stoiber, D (2011): Role of Tyk2 in T-cell mediated tumor surveillance. -YSA of the Medical University Vienna /PhD-Symposium (Vienna, Young Scientist Association of the Medical University Vienna); JUN 15-16, 2011; Vienna, Austria.

Hainzl, E; Rauch, I; Heider, S; Kenner, L; Decker, T; Strobl, B; Müller, M (2011): Tyrosine kinase 2 protects from chemically-induced colitis via amplification of interleukin-22 signalling. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, OCT 09-12, 2011. Cytokine (56), S1 32-32.

Hainzl, E; Rauch, I; Heider, S; Kenner, L; Decker, T; Strobl, B; Müller, M (2011): Tyrosine kinase 2 protects from chemically-induced colitis via amplification of interleukin-22 signalling. -9th Joint Meeting of the ICS/ISICR; Okt 9-12, 2011; Florence, Italy.

Katholnig, K; Kopecky, C; Hayakawa, H; Lassnig, C; Müller, M; Park, J; Säemann, M; Weichhart, T (2011): p38 regulates innate immune responses via mTOR to restrict Th1-cell differentiation. -YSA of the Medical University Vienna /PhD-Symposium (Vienna, Young Scientist Association of the Medical University Vienna).; JUN 15-16, 2011; Vienna, Austria.

Kernbauer, L; Strobl, B; Müller, M; Decker, T (2011): Conditional Stat1 ablation reveals the importance of interferon signalling for innate and adaptive immunity to Listeria monocytogenes infection. -The EMBO Meeting Advancing the Life Sciences; SEP 10-13, 2011; Vienna, Austria.

Köprülü, A; Kastner, R; Wienerroither, S; Lassnig, C; Müller, M; Decker, T; Ellmeier, W (2011): The role of Tec family kinases in macrophages. -YSA of the Medical University Vienna /PhD-Symposium (Vienna, Young Scientist Association of the Medical University Vienna); JUN 15-16, 2011; Vienna, Austria.

Marschall, J; Wölbing, F; Lassning, C; Schulte, U; Kolb, A; Whitelaw, B; Müller, M; Biedermann, T; Huber, M (2011): CD13 is a negative regulator of antigen-triggered mast cell activation in vitro and in vivo. -15th STS Meeting 2011: Signal Transuction - Receptors, Mediators and Genes ; NOV 7-9, 2011; Weimar, Germany.

Nivarthi, H; Tsyrulnyk, A; Warsch, W; Wang, ZQ; Winkler, S; Kenner, L; Müller, M; Baum, C; Bunting, KD; Sexl, V; Rülicke, T; Moriggl, R (2011): Generation of a Transgenic Mouse with Inducible Constitutively Active Stat5a. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA, DEC 10-13, 2011. Blood (118), 21 1456-1456.

Prchal, M; Kobolak, J; Teppner, I; Wallner, B; Semper, C; Lassing, C; Putz, EM; Dinnyes, A; Kolbe, T; Rulicke, T; Karaghiosoff, M; Sexl, V; Strobl, B; Müller, M (2011): Dissection of kinase-dependent and -independent functions of Tyk2 in immunity to infection and tumor-surveillance. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, OCT 09-12, 2011. Cytokine (56), 1 86-86.

Prchal, M; Kobolak, J; Teppner, I; Wallner, B; Semper, C; Lassnig, C; Putz, EM; Dinnyes, A; Kolbe, T; Rülicke, T; Karaghiosoff, M; Sexl, V; Strobl, B; Müller, M (2011): Dissection of kinase-dependent and -independent functions of Tyk2 in immunity to infection and tumor-surveillance. -9th Joint Meeting of the ICS/ISICR; OKT 9-12, 2011; Florence, Italy.

Putz, EM; Zebedin-Brandl, EM; Decke, T; Prchal, M; Müller, M; Sexl, V (2011): STAT1 serine phosphorylation - putting the brakes on NK cell activity. -9th Joint Meeting of the ICS/ISICR; OKT 9-12, 2011; Florence, Italy.

Putz, EM; Zebedin-Brandl, EM; Decker, T; Prchal, M; Müller, M; Sexl, V (2011): STAT1 serine phosphorylation - Putting the brakes on NK cell activity. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, OCT 09-12, 2011. Cytokine (56), 1 87-87.

Rauch, I; Hainzl, E; Heider, S; Strobl, B; Müller, M; Kenner, L; Decker, T (2011): Type I Interferons interfere with resolving inflammation of DSS induced acute colonic disease. -Microbiota and mucosal immunology: The interface in health and disease; April 14-16, 2011; San Francisco USA.

Semper, C; Leitner, NR; Lassnig, C; Rammerstorfer, M; Kolbe, T; Rülicke, T; Müller, M; Strobl, B (2011): Stat1 isoform functions: insights from knockin mice. Celebrating the 20th year of Jak-STAT research, highlighting recent basic developments in the field, relevance to diseases and new therapeutics; SEP 22-24, 2011; Bethesda, USA. 2011.

Stiefvater, R; Vielnascher, RM; Hofmann, E; Reichart, U; Kolbe, T; Gerner, W; Popp, D; Vogl, C; Karaghiosoff, M; Müller, M; Strobl, B (2011): Conditional knockout of tyrosine kinase 2 (Tyk2): dissecting cell type-specific functions in innate IL-17 production. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, OCT 09-12, 2011. Cytokine (56), 1 90-90.

Stiefvater, R; Vielnascher, RM; Hofmann, E; Reichart, U; Kolbe, T; Gerner, W; Popp, D; Vogl, C; Karaghiosoff, M; Müller, M; Strobl, B (2011): Conditional knockout of tyrosine kinase 2 (Tyk2): dissecting cell type-specific functions in innate IL-17 production. -9th Joint Meeting of the ICS/ISICR; Okt 9-12, 2011; Florence, Italy.

Bourgeois, C; Majer, O; Frohner, I; Lesiak-Markowicz, I; Hildering, KS; Glaser, W; Stockinger, S; Decker, T; Akira, S; Müller, M; Kuchler, K (2010): Candida species trigger a type I interferon-response in conventional dendritic cells requiring novel phagosomal TLR-mediated IFN beta signaling. 44th Annual Meeting of the German-Speaking Mycological Society (DMykG) together with the Austrian Society of Medical Mycology (ÖGMM), Vienna, Austria, SEP 9–11, 2010. Mycoses (53), 5 404-405.

Farlik, M; Reutterer, B; Schindler, C; Greten, F; Vogl, C; Müller, M; Decker, T (2010): STAT-NF kappa B interaction in the regulation of antimicrobial genes through nonconventional assembly of a transcription initiation complex. 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Research, Chicago, IL, OCT 03-07, 2010. Cytokine (52), 1-2 15-15.

Leitner, NR; Kolbe, T; Lassnig, C; Hochedlinger, K; Rülicke, T; Müller, M (2010): Inducible STAT1 protein in mice. 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Research, Chicago, IL, OCT 03-07, 2010. Cytokine (52), 1-2 31-32.

Semper, C; Leitner, NR; Rammerstorfer, M; Kolbe, T; Rülicke, T; Strobl, B; Müller, M (2010): STAT1 alpha and STAT1 beta knockin mice: Initial findings and some surprises. 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Research, Chicago, IL, OCT 03-07, 2010. Cytokine (52), 1-2 31-31.

Stiefvater, R; Hofmann, E; Kolbe, T; Reichart, U; Lassnig, C; Vogl, C; Poli, V; Müller, M; Strobl, B (2010): TYK2 is required for IL-17 production by innate immune cells in response to IPS. 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Research, Chicago, IL, OCT 03-07, 2010. Cytokine (52), 1-2 31-31.

Anderl, S; Müller, S; Korthaus, D; Kolbe, T; Schmidt, V; Müller, M; Rülicke, T (2009): A new Kit-allel causing a mild phenotype in the mouse. Neujahrsempfang der Veterinärmedizinischen Universität Wien; 23.01.2009; Vienna, Austria. 2009.

Hofmann, E; Reichart, U; Gausterer, C; Guly, C; Meijer, D; Müller, M; Strobl, B (2009): Oct-6 is an interferon inducible protein and contributes to the transcriptional responses to poly(I:C). Tri-Society Annual Conference of the International-Cytokine-Society/International-Society-of-Interferon-and-Cytokine-Research/Society-of-Leukocyte-Biology, Lisbon, PORTUGAL, OCT 17-21, 2009. Cytokine (48), 1-2 88-88.

Grunert, T; Strobl, B; Marchetti, M; Miller, I; Radwan, M; Vogl, C; Gemeiner, M; Allmaier, G; Müller, M (2008): Proteomic study of Tyk2 deficient murine macrophages in response to poly I:C. -HUPO 2008 7th World Congress; AUG 16-20, 2008; Amsterdam, NETHERLANDS.

Kastner, R; Kernbauer, E; Stockinger, S; Westermayer, S; Pilz, A; Reutterer, B; Kalinke, U; Müller, M; Decker, T (2008): Cells of myeloid origin are required for type IIFN production and the enhancement of lethal Listeria monocytogenes infection. Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, Austria, September 3–6, 2008. Wien Klin Wochenschr (120) 149-150.

Leitner, N; Kolbe, T; Hochedlinger, K; Rülicke, T; Müller, M (2008): Inucible STAT1 Protein in Mice. 3. ESF Functional Genomics Conference; 01. - 04. 10. 2008; Innsbruck, Austria. 2008.

Majer, O; Bourgeois, C; Frohner, I; Stockinger, S; Müller, M; Decker, T; Kuchler, K (2008): Type I IFN signaling in fungal infections. Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, Austria, September 3–6, 2008. Wien Klin Wochenschr (120) 150-150.

Radwan, M; Miller, I; Grunert, T; Marchetti, M; Vogl, C; O'Donoghue, N; Dunn, MJ; Kolbe, T; Allmaier, G; Gemeiner, M; Müller, M; Strobl, B (2008): The Impact of Tyrosine Kinase 2 (Tyk2) on the Proteome of Murine Macrophages and their Response to Lipopolysaccharide (LPS). 3. ESF Functional Genomics Conference; 01. - 04. 10. 2008; Innsbruck, Österreich. 2008.

Rigler, D; Lajko, R; Kolbe, T; Rülicke, T; Donabauer, B; Vogl, C; Karaghiosoff, M; Müller, M (2008): Systemic IFN beta expression during LPS-induced shock in Irf7-, Ifnar1- and Tyk2-deficient mice. ÖGAI-Meeting, Vienna, Austria, Sept 3-6, 2008. Wien Klin Wochenschr (120) 88-88.

Schneider, A; Reichart, U; Gerner, W; Kolbe, T; Saalmüller, A; Müller, M (2008): Distinct impairment in the early activation via CD69 of Tyk2 deficient peritoneal macrophages and spleen cells upon LPS challenge. Annual Meeting of the European Macrophage & Dendritic cell society (EMDS); 17. - 20. 09. 2008; Brescia, Italien. 2008.

Stiefvater, R; Strobl, B; Hofmann, E; Kolbe, T; Reichart, U; Lassnig, C; Vogl, C; Poli, V; Müller, M (2008): Type I interferon-independent requirement of Tyk2 for LPS-mediated IL-17 expression in murine macrophages. Joint Annual Meeting of Immunology of the Austrian and German Societies (ÖGAI, DGfI), Vienna, Austria, September 3–6, 2008. Wien Klin Wochenschr (120), Suppl. 88-88.

Stiefvater, R; Strobl, B; Hofmann, E; Kolbe, T; Reichart, U; Lassnig, C; Vogl, C; Poli, V; Müller, M (2008): Type I interferon-independent requirement of Tyk2 for LPS-mediated IL-17expression in murine macrophages. Gemeinsames Jahrestreffen für Immunologie der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Deutschen Gesellschaft für Immunologie (DGfI); 03.-06.09.2008; Wien, Österreich. 2008.

Radwan, M; Miller, I; Strobl, B; Grunert, T; Dunn, M; Vogl, C; Marchetti, M; Allmaier, G; Gemeiner, M; Mueller, M (2007): The influence of Tyk2 deficiency on the murine macrophage proteome. 50th Anniversary of The Discovery of Interferons, Oxford, ENGLAND, SEP 16-19, 2007. J Interferon Cytokine Res (27), 8 727-727.

Bito, A; Constantino, G; Briza, P; Müller, M; Breitenbach, M (2006): The Candida albicans orthologues of the Dit1 and Dit2 yeast meiotic genes contribute to virulence of Candida. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 121-121.

Gausterer, C, Vogl, C; Steinborn, R; Teppner, I; Kobolak, J; Leitner, N; Wallner, B; Vielnascher, R; Hofmann, E; Kolbe, T; Dinnyes, A; Karaghiosoff, M; Müller, M; Strobl, B (2006): Dissection of kinase-dependent and -independent functions of murine Tyk2. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 30-30.

Leitner, N; Strobl, B; Bokor, M; Painz, R; Kolbe, T; Rülicke, T; Müller, M; Karaghiosoff, M (2006): A time- and dose-dependent Stat1 expression system. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 30-30.

Rigler, D; Karaghiosoff, M; Strobl, B; Lajko, R; Donabauer, B; Kolbe, T; Steinborn, R; Kalinke, U; Müller, M (2006): Selective requirement for the Janus kinase Tyk2 in TLR3 and TLR4 signaling dependent on the macrophage population. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 104-105.

Soulat, D; Reitterer, B; Bauch, A; Superti-Furga, G; Müller, M; Decker, T; Stockinger, S (2006): Listeria monocytogenes-induced IFN-b production is detrimental for the host and occurs through an unkown cytosolic pathway. Cytokines 2006, Vienna, Austria, August 2006. European Cytokine Network (17), S1 77-78.

Suess, B; Bruns, U; Hein, I; Müller, M; Wagner, M (2004): Performance testing of three different real-time PCR assays for the quantification of Salmonella spp. Quantification and detection of microbes by novel molecular tools. Wien, 04.-05.11.2004, p.31. , .

Costantino, G; Egerbacher, M; Kolbe, T; Karaghiosoff, M; Müller, M (2003): Tyk2-/- mice exhibit resistance to intestinal ischemia/reperfusion injury. European Journal of Biochemistry (270), Suppl. 1 176-176.

Shaw, MH; Boyartchuk, V; Wong, S; Karaghiosoff, M; Muller, M; Dietrich, WF; Yap, GS (2003): A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. 90th Annual Meeting of the American-Association-for-Immunologists, Denver, Colorado, MAY 06-10, 2003. Faseb J (17), 7 C152-C152.

Coulibaly, S; Besenfelder, U; Zinovieva, N; Miller, I; Gemeiner, M; Kotler, T; Jameson, JL; Müller, M; Brem, G (2000): Secretion of functional recombinant bovine follicle stimulating hormone in the milk of transgenic rabbits. 2000 Embryo Transfer Pioneer Award, Theriogenology (53), 1 512-512.

Bourgeois, C; Majer, O; Frohner, I; Stockinger, S; Costantino, G; Mueller, M; Decker, T; Kuchler, K (2007): Candida spp. activate interferon-type I response in mouse myeloid dendritic cells. Febs J 2007; 274: 192-192.

Radwan, M; Miller, I; Strobl, B; O'Donoghue, N; Dunn, M; Vogl, C; Gemeiner, M; Müller, M (2006): The influence of Tyk2 deficiency on the murine macrophage proteome. Immunoregulatory and Antimicrobial Activities of Myeloid Cells, Freiburg, 05.-07.10.2006. Immunoregulatory and Antimicrobial Activities of Myeloid Cells, Freiburg, 05.-07.10.2006.

Klymiuk, N; Mueller, M; Brem, G; Aigner, B (2005): Genomic characterization of the porcine endogenous retrovirus gamma 2 family. Xenotransplantation 2005; 12(5): 392-392.

Schuster, C; Schellack, C; Simma, O; Weisz, E; Muller, M; Sexl, V; Stoiber, D (2005): Loss of Tyk2 accelerates lymphoma formation in E mu-Myc transgenic mice. Pharmacology 2005; 75(4): 197-197.

Revilla-Fernández, S; Schmoll, F; Müller, M; Steinborn, R (2004): Exogenous and endogenous controls for qualitative and quantitative detection of porcine reproductive and respiratory syndrome virus (PRRSV) RNA in porcine samples. 1. Herbsttagung der österreichischen Schweinepraktiker "Von Praktikern für Praktiker", Vet. Med. Univ. Wien, 04.-06.11.2004. 1. Herbsttagung der österreichischen Schweinepraktiker "Von Praktikern für Praktiker", Vet. Med. Univ. Wien, 04.-06.11.2004.

Costantino, G; Wagner, M; Stroble, B; Egerbacher, M; Kolbe, T; Lajko, R; Karaghiosoff, M; Müller, M (2003): Tyk2-deficient mice show inceased susceptibility to Listeria monocytogenes. European Cytokine Network 14,(Suppl.Sept).

Laurincik, J; Avery, B; Müller, M; Schellander, K; Maddox-Hyttel, P (2003): Transcription of nucleolar proteins in bovine embryos produced in vitro. Theriogenology 59,

Leitner, N; Strobl, B; Kolbe, T; Deutschmann, M; Müller, M; Karaghiosoff, M (2003): Dose and time dependent expression of Stat1 in Stat1- and Tyk2-deficient cells and mice. European Cytokine Network 14,(Suppl.Sept).

Benczak, A; Revilla, S; Schmoll, F; Truschner, K; Müller, M; Steinborn, R (2002): Quantitative Real-Time RT-PCR for the detection of european and north american strains of PRRS virus in boar semen. 17th IPVS Congress 2002, Ames/Iowa, 1. - 8. 6. 2002. 17th IPVS Congress 2002, Ames/Iowa, 1. - 8. 6. 2002.

Kerschbaumer, P; Steinborn, R; Walzer, C; Müller, M; Schwarzenberger, F (2002): Mutationen der mitochondrialen DNA als mögliche Ursache für Krankheits-prädispostition und progressive neurodegenerative Erkrankungen bei Geparden (Acinonyx jubatus). 15. Tagung der Fachgruppe Physiologie und Biochemie der Deutschen Veterinärmedizinischen Gesellschaft, Wien, Austria, 27.2.-1.3.2002. 15. Tagung der Fachgruppe Physiologie und Biochemie der Deutschen Veterinärmedizinischen Gesellschaft, Wien, Austria, 27.2.-1.3.2002.

Kolbe, T; Nowshari, M. A; Bordoy, R; Troelsen, J. T; Brem, G; Müller, M (2002): Combination of microinjection and cryopreservation for the generation of transgenic micec. Theriogenology 57,

Revilla-Fernandez, S; Benczak, A; Höller, K; Schmoll, F; Schuh, M; Müller, M; Steinborn, R (2002): Molecular diagnostics of porcine reproductive and respiratory syndrome virus in serum, semen and tissues with different complexities using Real-time quantitative RT-PCR. Jahrestagung Gesellschaft für Virologie, Erlangen, Deutschland, 8. - 11. 4. 2002. Jahrestagung Gesellschaft für Virologie, Erlangen, Deutschland, 8. - 11. 4. 2002.

Bogdan, C; El-Gayar, S; Röllinghoff, M; Müller, M; Schindler, H (2001): Molecular aspects of the innate immune response to Leishmania parasites. In: Life Sciences 2001, ÖGBM Ö, ÖGBT, ed. (Vienna: ÖGBM, ÖGGGT, ÖGBT). p. 23. , .

Karaghiosoff, M; Steinborn, R; Kriegshaeuser, G; Kovarik, P; Decker, T; Müller, M (2001): Tyk2 deficient mice are highly resistant to LPS induced endotoxin shock. Scandinavian Journal of Immunology 54,(Suppl. 1).

Karaghiosoff, M; Steinborn, R; Kriegshauser, G; Kovarik, P; Decker, T; Müller, M (2001): Tyk2 deficient mice are highly resistant to LPS induced shock. In Life Sciences 2001, ÖGBM Ö, ÖGBT, ed. (Vienna: ÖGBM, ÖGGGT, ÖGBT), p. 73. , .

Klymiuk, N; Aigner, B; Müller, M; Brem, G (2001): Endogene Retroviren bei Schaf und Schwein. Vortragstagung der Deutschen Gesellschaft für Züchtungskunde e.V. und der Gesellschaft für Tierzuchtwissenschaften, München LfTT, Weihenstefan bei München: Lehrstuhl für Tierzucht TU München, Vortragstagung der Deutschen Gesellschaft für Züchtungskunde e.V. und der Gesellschaft für Tierzuchtwissenschaften, München LfTT, Weihenstefan bei München: Lehrstuhl für Tierzucht TU München, .

Kucera, K; Müller, M; Müller, S (2001): Multiplex PCR caniner Mikrosatelliten zur Klärung forensischer Fragestellungen. In Vortragstagung der Deutschen Gesellschaft für Züchtungskunde e.V. und der Gesellschaft für Tierzuchtwissenschaften, München LfTT, ed. (Weihenstefan bei München: Lehrstuhl für Tierzucht TU München), p. B26. , .

Luksch, U; Müller, M; Brem, G (2001): Detektion toxinbildender Pasteurella multocida Stämme mit Hilfe molekulardiagnostischer Methoden. In Vortragstagung der Deutschen Gesellschaft für Züchtungskunde e.V. und der Gesellschaft für Tierzuchtwissenschaften, München LfTT, ed. (Weihenstefan bei München: Lehrstuhl für Tierzucht TU München), In Vortragstagung der Deutschen Gesellschaft für Züchtungskunde e.V. und der Gesellschaft für Tierzuchtwissenschaften, München LfTT, ed. (Weihenstefan bei München: Lehrstuhl für Tierzucht TU München), .

Müller, M; Brem, G (2001): Mammary gland and blood specific expression of foreign proteins in rabbits. In 10th European Congress on Biotechnology, Mellado RP, ed. (Madrid: European Federation of Biotechnology), p. 46. , .

Müller, M; Brem, G (2001): Gene farming. In 3rd Trans-Tech-Meeting, Wilbertz, J., Bereczky-Veress, B., eds. (Karolinska Institut Stockholm: Karolinska Institut), p. 27-29. , .

Vielnascher, R; Karaghiosoff, M; Kolbe, T; Müller, M (2001): Herstellung von Tyk2-defizienten embryonalen Stammzellen. Deutsche Gesellschaft für Züchtungskunde e.V. und Gesellschaft für Tierzuchtwissenschaften, München, C 21, Deutsche Gesellschaft für Züchtungskunde e.V. und Gesellschaft für Tierzuchtwissenschaften, München, C 21, .

Wallner, B; Müller, M; Brem, G; Achmann, R (2001): Gezielte Isolierung von Y-chromosomalen DNA-Sequenzen beim Pferd und deren Anwendbarkeit zur Charakterisierung phylogenetischer Beziehungen.In Vortragstagung der Deutschen Gesellschaft für Züchtungskunde e.V. und der Gesellschaft für Tierzuchtwissenschaften, München LfTT. , .

Mösslacher, G; Besenfelder, U; Schmoll, F; Mahabir, E; Schneider, H; Köster, M; Hyttel, P; Laurincik, J; Müller, M; Brem, G; Schellander, K (2000): Endoskopische Gewinnung früher Embryonalstadien beim Rind. Jahrestagung der deutschsprachigen Arbeitsgemeinschaft Embryotranser - AET-d, Verden, Deutschland, 29.-30.6.2000. Jahrestagung der deutschsprachigen Arbeitsgemeinschaft Embryotranser - AET-d, Verden, Deutschland, 29.-30.6.2000.

Walter, I; Petznek, H; Klein, D; Rigler, D; Müller, M; Salmons, B; Günzburg, W.H; Renner, M. Scanning (2000): Confocal laser scanning microscopy of enhanced green fluorescent protein (EGFP) expression in transgenic mice. San Antonio, Texas, 9.-12.05.2000. Scanning 22,

Gelbmann, W; Klein, D; Walter, I; Müller, M; Fleischmann, M; Hanak-Hammerl, A; Renner, M; Salmons, B; Günzburg, W.H (1999): In Vivo Gene Therapy Models Targeting Metastatic Breast Cancer. 7th Meeting of the European Society of Gene Therapy, München, DE, 1999. The Journal of Gene Medicine 1,(Suppl. 6).

© University of Veterinary Medicine ViennaHelp and Downloads